Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.

Saved in:
Bibliographic Details
Title: Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.
Authors: Patmore LA; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, the Netherlands., Carey I; Institute of Liver Studies, King's College Hospital, London, UK., Feld JJ; Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, Canada., Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, the Netherlands., Patel K; Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, Canada., Buti M; Liver Unit, Hospital University Valle d'Hebron and CIBEREHD del INstinuto Carlos III, Barcelona, Spain., Honkoop P; Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Postma DF; Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, Groningen, the Netherlands., Blokzijl H; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, the Netherlands., Koc ÖM; Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands., van Oorschot E; Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands., Agarwal K; Institute of Liver Studies, King's College Hospital, London, UK., van der Valk M; Stichting HIV Monitoring, Amsterdam, the Netherlands., Lieveld FI; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, the Netherlands., Kilany M; Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, Canada., Kramer M; Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., de Bruijne J; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands., Claassen MAA; Department of Internal Medicine and Infectious Diseases, Rijnstate Hospital, Arnhem, the Netherlands.; Department of Infectious Diseases, Amsterdam Institute for Immunology & Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Hansen BE; Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, the Netherlands., de Man RA; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, the Netherlands., Janssen HLA; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, the Netherlands.; Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, Canada., Takkenberg RB; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, the Netherlands., Sonneveld MJ; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, the Netherlands.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Feb; Vol. 63 (3), pp. 374-382. Date of Electronic Publication: 2025 Sep 09.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2036
DOI:10.1111/apt.70360